700 likes | 828 Views
Strategy Planning Process. Agenda. Interviews (JESS) mHealth ecosystem (RYA) D-tree product strategy (TOGETHER) D-tree business model (RYA) Creating internal alignment (JESS) Strategy definition process (RYA) Elephants (TOGETHER) Appendix. Interviews: What we heard.
E N D
Agenda • Interviews (JESS) • mHealthecosystem (RYA) • D-tree product strategy (TOGETHER) • D-tree business model (RYA) • Creating internal alignment (JESS) • Strategy definition process (RYA) • Elephants (TOGETHER) • Appendix Week 1: Product and Process Review v. 1.0
Mix between believers and skeptics in potential of mhealth Week 1: Product and Process Review v. 1.0
mHealth interventions encounter similar problems in scale and siloing Week 1: Product and Process Review v. 1.0
Major players clearly identified by interviewees Week 1: Product and Process Review v. 1.0
Agreement over role of partnerships… Week 1: Product and Process Review v. 1.0
And some agreement about role of different sectors • But general feeling that current players unable to bring to scale alone or at all Week 1: Product and Process Review v. 1.0
Differing ideas about greatest area of need • CHW vs. Facility • Communication vs. logistics Week 1: Product and Process Review v. 1.0
Inconsistent views of D-tree Week 1: Product and Process Review v. 1.0
mHealth ecosystem Week 1: Product and Process Review v. 1.0
mHealth hitting every part of health system • Health system diagram with examples
In the middle of a bubble Week 1: Product and Process Review v. 1.0
Scale rarely yet achieved, with some exceptions Week 1: Product and Process Review v. 1.0
Not significant focus on impact at present Week 1: Product and Process Review v. 1.0
Increasing entrance of major players Week 1: Product and Process Review v. 1.0
Case study: Novartis / SMS for Life Week 1: Product and Process Review v. 1.0
Case study: Grameen Intel Week 1: Product and Process Review v. 1.0
Funding still remains essential simple models and sustainability not yet cracked Week 1: Product and Process Review v. 1.0
Current D-tree portfolio and competitive advantage • And why this is not strongest it could Week 1: Product and Process Review v. 1.0
Create focus and expertise • Key decision areas
Solutions provider vs. discrete product/service Week 1: Product and Process Review v. 1.0
Hardware • Cannot scale and be hardware supporter
Implementation and Training Week 1: Product and Process Review v. 1.0
Evaluating points of impact Week 1: Product and Process Review v. 1.0
Geography Week 1: Product and Process Review v. 1.0
Recommendations Week 1: Product and Process Review v. 1.0
Competitive analysis • With strong competitors prodcut differentiation important Week 1: Product and Process Review v. 1.0
Designing the system Don’t know where go • Incentives • Frontline provider • Doctor • Patient • Tracking—what happens after referral • Evaluation • Measuring impact Week 1: Product and Process Review v. 1.0
Possible growth and development trajectories Don’t know where go Week 1: Product and Process Review v. 1.0
Possible roadblocks Don’t know where go • Protocols hard to sell • NGOs/gov’t management Week 1: Product and Process Review v. 1.0
Provider models • Pay point of care • Subcontract as systems specialist • Develop own clinics • Clinic in a phone—entrepreneur, franchise • Bricks and mortar • Telemedicine
Provider model analysis Week 1: Product and Process Review v. 1.0
Payor models • Insurance • Government • National • Foreign • NGOs Week 1: Product and Process Review v. 1.0
Payor model analysis Week 1: Product and Process Review v. 1.0
Medical research models • Pharma • Government • National • Foreign • UN/WHO? • University Week 1: Product and Process Review v. 1.0
Research model analysis Week 1: Product and Process Review v. 1.0
Adjacent industries • Telecomm • Hardware • Software Week 1: Product and Process Review v. 1.0
Telecomm Analysis Relevance to D-tree Week 1: Product and Process Review v. 1.0 Direct revenue Access to markets
Roles Week 1: Product and Process Review v. 1.0